ArticleCancers2022

Quality of Life in Cutaneous T-cell Lymphoma Patients Receiving Mogamulizumab: Important Factors to Consider.

Rosanne Ottevanger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.